Pharming appoints Anurag Relan as Chief Medical Officer and Robert Friesen as Chief Scientific Officer
Pharming Group announces the appointment of Anurag Relan as Chief Medical Officer (CMO), effective immediately, and Robert Friesen as Chief Scientific Officer, effective from 1 August 2021.
Anurag and Robert will be the successors of Bruno Giannetti, who was Chief Operating Officer (2006 - 2019) and Chief Medical Officer from 2019. Bruno announced his retirement from the Executive Committee at Pharming’s recent Annual General Meeting of Shareholders, Bruno will stay with the company on a consultancy basis.
We welcome both Anurag and Robert to our executive committee, Both appointments will also be crucial as we remain focused on our ambitious growth strategy, including expanding our pipeline of opportunities
- Sijmen de Vries - CEO